Antibody–drug conjugates come of age in oncologyCharles Dumontet, Alain Beck, Peter D. Senter et al.|Nature Reviews Drug Discovery|2023Cited by 772
Adipose cells promote resistance of breast cancer cells to trastuzumab-mediated antibody-dependent cellular cytotoxicityMinh Ngoc Duong, Charles Dumontet|Breast Cancer Research|2015Cited by 104
<i>In Vivo</i> Syngeneic Tumor Models with Acquired Resistance to Anti–PD-1/PD-L1 TherapiesMorgane Denis, Charles Dumontet|Cancer Immunology Research|2022Cited by 31
A systemically administered detoxified TLR4 agonist displays potent antitumor activity and an acceptable tolerance profile in preclinical modelsKamel Chettab, Charles Dumontet|Frontiers in Immunology|2023Cited by 13